Literature DB >> 3141628

Infectious complications in patients with severe head injury.

T S Helling1, L L Evans, D L Fowler, L V Hays, F R Kennedy.   

Abstract

Mortality and morbidity from head trauma have been substantially reduced by improved prehospital care and aggressive diagnostic and therapeutic management. However, a substantial number of patients will require prolonged periods of hospitalization, intensive care, and ventilator support during their recovery, placing them at risk for infectious complications. Eighty-two such patients were reviewed during a 30-month period at a Level I trauma center. Forty-one patients (50%) developed at least one infectious complication. The most common source was respiratory, occurring in 34 patients relatively early (average, 3.2 days) in their hospital course. The severity of head injury and presence of coexisting thoracic trauma correlated statistically; administration of prophylactic antibiotics and corticosteroids did not in the development of infectious problems. Only three patients died as a result of sepsis, indicating that early recognition and prompt treatment may control the severity of infectious complications.

Entities:  

Mesh:

Year:  1988        PMID: 3141628     DOI: 10.1097/00005373-198811000-00009

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  20 in total

1.  Cerebrospinal fluid leakage complicating skull base fractures: analysis of 81 cases.

Authors:  Selcuk Yilmazlar; Erhan Arslan; Hasan Kocaeli; Seref Dogan; Kaya Aksoy; Ender Korfali; Muammer Doygun
Journal:  Neurosurg Rev       Date:  2005-06-04       Impact factor: 3.042

2.  Severe traumatic head injury affects systemic cytokine expression.

Authors:  Damien J LaPar; Laura H Rosenberger; Dustin M Walters; Traci L Hedrick; Brian R Swenson; Jeffrey S Young; Lesly A Dossett; Addison K May; Robert G Sawyer
Journal:  J Am Coll Surg       Date:  2012-02-17       Impact factor: 6.113

Review 3.  Treatment of Temporal Bone Fractures.

Authors:  Rodney C Diaz; Brian Cervenka; Hilary A Brodie
Journal:  J Neurol Surg B Skull Base       Date:  2016-06-02

4.  The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury.

Authors:  Nicholas R Nelson; Kathryn A Morbitzer; J Dedrick Jordan; Denise H Rhoney
Journal:  Neurocrit Care       Date:  2019-02       Impact factor: 3.210

5.  Physiotherapy does not prevent, or hasten recovery from, ventilator-associated pneumonia in patients with acquired brain injury.

Authors:  Shane Patman; Sue Jenkins; Kathy Stiller
Journal:  Intensive Care Med       Date:  2008-09-24       Impact factor: 17.440

6.  Safety and tolerability of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial.

Authors:  Anna Teresa Mazzeo; Gretchen M Brophy; Charlotte B Gilman; Oscar Luís Alves; Jaime R Robles; Ronald L Hayes; John T Povlishock; M Ross Bullock
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

7.  Antibiotic prophylaxis for intracranial pressure monitors.

Authors:  D G Jacobs; A Westerband
Journal:  J Natl Med Assoc       Date:  1998-07       Impact factor: 1.798

8.  Prophylactic antibiotic for prevention of posttraumatic meningitis after traumatic pneumocephalus: design and rationale of a placebo-controlled randomized multicenter trial [ISRCTN71132784].

Authors:  Behzad Eftekhar; Mohammad Ghodsi; Azar Hadadi; Mousa Taghipoor; Samira Zabihyan Sigarchi; Vafa Rahimi-Movaghar; Ehsan Sherafat Kazemzadeh; Babak Esmaeeli; Farideh Nejat; Alireza Yalda; Ebrahim Ketabchi
Journal:  Trials       Date:  2006-01-18       Impact factor: 2.279

9.  Substance P mediates reduced pneumonia rates after traumatic brain injury.

Authors:  Sung Yang; David Stepien; Dennis Hanseman; Bryce Robinson; Michael D Goodman; Timothy A Pritts; Charles C Caldwell; Daniel G Remick; Alex B Lentsch
Journal:  Crit Care Med       Date:  2014-09       Impact factor: 7.598

10.  Impact of associated injuries in the floating knee: a retrospective study.

Authors:  Ulfin Rethnam; Rajam S Yesupalan; Rajagopalan Nair
Journal:  BMC Musculoskelet Disord       Date:  2009-01-14       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.